Charles Bridges Email

Chief Scientific Officer and EVP . CorVista Health

Current Roles

Employees:
38
Revenue:
$4.8M
About
CorVista Health is applying machine learning to develop a novel cardiac diagnostic platform, CorVista® System, with the aim of transforming cardiovascular care and the patient experience. The CorVista System is a non-invasive, point-of-care solution that allows physicians to evaluate heart function without radiation, contrast agents, injections, fasting or exercise. For more information, visit www.corvista.com. The CorVista System is an investigational device limited by federal law to investigational use. The CorVista System is not available for commercial distribution.
CorVista Health Address
160 Bloor St. East
Toronto, ON
CAN
CorVista Health Email

Past Companies

CorVista® HealthChief Scientific Officer and Executive Vice President
The Janssen Pharmaceutical Companies of Johnson & JohnsonChief Technology Officer, Cardiovascular, Metabolism and Pulmonary Hypertension Therapeutic Areas
Johnson and Johnson, Janssen PharmaceuticalsChief Technology Officer, Pulmonary Hypertension Therapeutic Area

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.